中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
32期
55-56,57
,共3页
郑锦鹏%陈奕新%陈丽香%林小苑%李耀平%吴利炜
鄭錦鵬%陳奕新%陳麗香%林小苑%李耀平%吳利煒
정금붕%진혁신%진려향%림소원%리요평%오리위
肠道灌注%全结肠系膜切除%结肠癌根治%远期效果
腸道灌註%全結腸繫膜切除%結腸癌根治%遠期效果
장도관주%전결장계막절제%결장암근치%원기효과
Intestinal perfusion%Removing mesocolon%Cure for colon cancer%The long-term curative effect
目的:观察肠道灌注加全结肠系膜切除治疗结肠癌的远期疗效。方法:将本院28例TNM分期为Ⅰ~Ⅲ期结肠癌患者随机分为两组,观察组11例采用肠道灌注加全结肠系膜切除治疗方法;对照组17例采用传统根治术治疗方法。观察两组治疗效果。结果:两组手术时间、术中出血、术后排气、术后进食时间以及并发症方面比较差异无统计学意义(P>0.05);观察组3年无局部复发病例,5年存活率90.90%(10/11);对照组3年内局部复发病例2例,5年存活率76.47%(13/17),观察组治疗效果及5年生存率均优于对照组。结论:肠道灌注加全结肠系膜切除治疗结肠癌能明显提高生存率,降低复发率,值得临床推广应用。
目的:觀察腸道灌註加全結腸繫膜切除治療結腸癌的遠期療效。方法:將本院28例TNM分期為Ⅰ~Ⅲ期結腸癌患者隨機分為兩組,觀察組11例採用腸道灌註加全結腸繫膜切除治療方法;對照組17例採用傳統根治術治療方法。觀察兩組治療效果。結果:兩組手術時間、術中齣血、術後排氣、術後進食時間以及併髮癥方麵比較差異無統計學意義(P>0.05);觀察組3年無跼部複髮病例,5年存活率90.90%(10/11);對照組3年內跼部複髮病例2例,5年存活率76.47%(13/17),觀察組治療效果及5年生存率均優于對照組。結論:腸道灌註加全結腸繫膜切除治療結腸癌能明顯提高生存率,降低複髮率,值得臨床推廣應用。
목적:관찰장도관주가전결장계막절제치료결장암적원기료효。방법:장본원28례TNM분기위Ⅰ~Ⅲ기결장암환자수궤분위량조,관찰조11례채용장도관주가전결장계막절제치료방법;대조조17례채용전통근치술치료방법。관찰량조치료효과。결과:량조수술시간、술중출혈、술후배기、술후진식시간이급병발증방면비교차이무통계학의의(P>0.05);관찰조3년무국부복발병례,5년존활솔90.90%(10/11);대조조3년내국부복발병례2례,5년존활솔76.47%(13/17),관찰조치료효과급5년생존솔균우우대조조。결론:장도관주가전결장계막절제치료결장암능명현제고생존솔,강저복발솔,치득림상추엄응용。
Objective:To observe the long-term curative effect for colon cancer by using intestinal perfusion and removing mesocolon. Method:28 TNM cases with colon cancer of three levels(from I to III)were randomly divided into the observation group with 11 cases,applied treatment of using intestinal perfusion and removing mesocolon and the control group with 17 cases used traditional treatment of radical correction. Result:Compared the operation time,intraoperative bleeding,postoperative exhaust,eating time and postoperative complications of two groups,the differences had no statistical significance(P>0.05);No local recrudescence in three years in the observation group,with the total fraction surviving of 90.90%(10/11),compared with 2 local recrudescence in three years in the control group with the total fraction surviving of 76.47%(13/17)within a period of 5 years;Treatment effect and the 5-year survival rate in observation group were better than the control group. Conclusion:The treatment by using intestinal perfusion and removing mesocolon for carcinoma of colon is able to apparently improve the survival rate,and reduce the recurrence rate,and thus is worth clinical application.